BC
FOLD

Brookfield Corp’s Amicus Therapeutics FOLD Stock Holding History

Brookfield Corp’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-111,751
Closed -$1.17M – 645
2022
Q3 		$1.17M Sell
111,751
-403,249
-78% -$4.49M ﹤0.01% 521
2022
Q2 		$5.53M Sell
515,000
-95,000
-16% -$782K 0.02% 233
2022
Q1 		$5.78M Sell
610,000
-190,000
-24% -$1.78M 0.02% 234
2021
Q4 		$9.24M Sell
800,000
-45,000
-5% -$502K 0.04% 133
2021
Q3 		$8.07M Buy
845,000
+350,822
+71% +$3.59M 0.03% 158
2021
Q2 		$4.76M Buy
494,178
+14,500
+3% +$142K 0.02% 226
2021
Q1 		$4.74M Buy
+479,678
New +$7.42M 0.02% 170

Other funds holding FOLD

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return